Work

Selinexor for relapsed or refractory diffuse large B-cell lymphoma: examining the artifact

Year: 2020

Type: letter

Source: The Lancet Haematology

DOI: 10.1016/s2352-3026(20)30290-8

Authors: Stephen D Smith, Ajay K Gopal

Institutions: University of Washington, Fred Hutch Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, Bayer, Merck, Gilead Sciences, Portola Pharmaceuticals

OpenAlex ID: W3089094196

Cites: 4

Cited by: 2

Related to: 10